
    
      Outpatients attending the hospital clinics/study centres will be recruited. Patients with
      moderate to severe COPD airflow obstruction according to GOLD 2015 criteria.

      A total of approximately 300 patients will be enrolled.

      Patients are followed during 3 different treatment periods of 4 weeks separated each by 3
      weeks wash-out period. The study lasts approximately 21 weeks for each patient and a total of
      11 clinic visits is performed during the study.

      The primary endpoint is the Forced Expiratory Volume in 1 second (FEV1) Area Under the Curve
      (AUC) 0-12h normalised by time on Day 28.
    
  